The company, which traces its origins to a medicine wholesale business opened in Osaka in 1781, bought Millennium Pharmaceuticals Inc. for $8.9 billion in 2008. Nordic Capital, based in Stockholm, owns 41 percent of Nycomed, while Credit Suisse���s DLJ...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Takeda to Buy Nycomed for 9.6 Bln Euros to Fill Sales Gap
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account